11C-HY-2-15 PET

Recruiting

99 years and younger

All

Phase N/A

20 participants needed

1 Location

Brief description of study

Primary Objectives

        Determine biodistribution of the radioactive investigational drug, 11C HY-2-15 and calculate human dosimetry (at least 10 male and female participants).
        Demonstrate the feasibility of imaging the brain with the novel imaging agent 11C HY-2-15
        Determine the most appropriate data analysis methodology.
        Determine whether there is selective uptake of 11C HY-2-15 in people with MSA compared to healthy volunteers, PD and PSP participants.

Secondary Objectives

Evaluate the safety of 11C HY-2-15 biodistribution and dosimetry for 11C-HY-2-15 in humans Feasibility of imaging with 11C-HY-2-15 Comparison of MSA brain uptake vs PD, PSP and healthy controls

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
Medical Research
Age: - 99 Years
Gender: All

TBD

Updated on 08 May 2024. Study ID: 853636

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).